Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edirol in bisphosphonate non-responding osteoporosis
NCT02306187Phase 1Unknown
- Sponsor
- Shinshu University
- Start
- Dec 2014
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of alfacalcidol + calcium carbonate in osteoporosis, sponsored by Shinshu University. Primary endpoint: Bone turnover markers at 4 months. Status: unknown.
02
Drugs
alfacalcidol + calcium carbonate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02306187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306187.